MOS
CASC

MGO One Seven’s Cascadian Therapeutics, Inc. CASC Stock Holding History

MGO One Seven’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-344
Closed -$1K – 1963
2017
Q4 		$1K Buy
+344
New +$1.41K ﹤0.01% 1751

MGO One Seven's CASC Position: Q1 2018 in Review

MGO One Seven sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 344 shares — an estimated $1K sold.

MGO One Seven first reported a position in CASC in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

  • MGO One Seven reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • MGO One Seven sold 344 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $1K.
  • MGO One Seven first reported a position in Cascadian Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • MGO One Seven's Cascadian Therapeutics, Inc. position peaked at $1K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.